Abstract | CONTEXT: OBJECTIVE: DESIGN: Immunoreactivity for tyrosinase, HMB-45 (anti-gp100 protein), S100 protein, CD34, and vimentin was studied in 70 tumors, including 15 melanomas (5 desmoplastic, 4 amelanotic, 6 melanotic), 13 malignant peripheral nerve sheath tumors; 10 schwannomas (1 pigmented), 12 neurofibromas (4 pigmented), and 20 fibrohistiocytic tumors (10 dermatofibrosarcoma protuberans and 10 dermatofibromas). Microwave-based antigen retrieval was performed in 10mM citrate buffer, pH 6.0, for 20 minutes at 121 degrees C. RESULTS: CONCLUSIONS: Our results support the sensitivity of tyrosinase expression and demonstrate the relative specificity of tyrosinase as a marker for melanocytic lesions, including desmoplastic melanoma, although pigmented peripheral nerve tumors may demonstrate focal positive staining. Immunoreactivity for tyrosinase and HMB-45 may have been enhanced by the microwave-based antigen-retrieval technique used in this study.
|
Authors | Jenny L Boyle, Helen M Haupt, Jere B Stern, Hinke A B Multhaupt |
Journal | Archives of pathology & laboratory medicine
(Arch Pathol Lab Med)
Vol. 126
Issue 7
Pg. 816-22
(Jul 2002)
ISSN: 0003-9985 [Print] United States |
PMID | 12088451
(Publication Type: Journal Article)
|
Chemical References |
- Antigens, CD34
- Antigens, Neoplasm
- Biomarkers, Tumor
- Melanoma-Specific Antigens
- Neoplasm Proteins
- S100 Proteins
- Vimentin
- Monophenol Monooxygenase
|
Topics |
- Antigens, CD34
(analysis)
- Antigens, Neoplasm
- Biomarkers, Tumor
(analysis)
- Dermatofibrosarcoma
(chemistry, enzymology, secondary)
- Diagnosis, Differential
- Humans
- Immunoenzyme Techniques
- Melanoma
(chemistry, enzymology, secondary)
- Melanoma-Specific Antigens
- Monophenol Monooxygenase
(analysis, metabolism)
- Neoplasm Proteins
(analysis)
- Nerve Sheath Neoplasms
(chemistry, enzymology, secondary)
- S100 Proteins
(analysis)
- Skin Neoplasms
(chemistry, enzymology, pathology)
- Vimentin
(analysis)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|